T1	PROC 44 73	Estudio de la calidad de vida
T2	DISO 89 116	migraña crónica o episódica
T3	DISO 138 152	comorbilidades
#1	AnnotatorNotes T3	C1275743; Co-morbid conditions; Finding
T4	PROC 207 261	Estudio multicéntrico, prospectivo, fase IIIb, abierto
T5	PROC 278 289	tratamiento
#2	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	PROC 295 346	evaluar la calidad de vida relacionada con la salud
T7	DISO 371 398	migraña crónica o episódica
T8	DISO 454 468	comorbilidades
#3	AnnotatorNotes T8	C1275743; Co-morbid conditions; Finding
T9	DISO 501 508	Migraña
#4	AnnotatorNotes T9	C0149931; Migraine Disorders; Disease or Syndrome
T10	PROC 534 563	Estudio de la calidad de vida
T11	DISO 579 606	migraña crónica o episódica
T12	DISO 628 642	comorbilidades
#5	AnnotatorNotes T12	C1275743; Co-morbid conditions; Finding
T13	PROC 756 780	consentimiento informado
#6	AnnotatorNotes T13	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T14	PROC 902 915	diagnosticado
#7	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	DISO 920 947	migraña crónica y episódica
T16	Observation 978 982	aura
#8	AnnotatorNotes T16	C0236018; Aura; Finding
T17	PROC 1132 1143	diagnóstico
#9	AnnotatorNotes T17	C0011900; Diagnosis; Diagnostic Procedure
T18	DISO 1202 1216	comorbilidades
#10	AnnotatorNotes T18	C1275743; Co-morbid conditions; Finding
T19	DISO 1229 1243	fatiga crónica
#11	AnnotatorNotes T19	C0518656; Chronic fatigue; Finding
T20	DISO 1245 1257	fibromialgia
#12	AnnotatorNotes T20	C0016053; Fibromyalgia; Disease or Syndrome
T21	PROC 418 426	tratados
#13	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	CHEM 1329 1353	anticuerpos monoclonales
#14	AnnotatorNotes T22	C0003250; Monoclonal Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T23	DISO 1362 1369	migraña
#15	AnnotatorNotes T23	C0149931; Migraine Disorders; Disease or Syndrome
T24	CHEM 666 674	erenumab
#16	AnnotatorNotes T24	C4542165; erenumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T25	CHEM 1459 1480	anticuerpo monoclonal
#17	AnnotatorNotes T25	C0003250; Monoclonal Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T26	DISO 1525 1532	migraña
#18	AnnotatorNotes T26	C0149931; Migraine Disorders; Disease or Syndrome
T27	DISO 1546 1553	migraña
#19	AnnotatorNotes T27	C0149931; Migraine Disorders; Disease or Syndrome
T28	PROC 1310 1318	tratados
#20	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	DISO 1762 1769	migraña
#21	AnnotatorNotes T29	C0149931; Migraine Disorders; Disease or Syndrome
T30	DISO 1811 1818	migraña
#22	AnnotatorNotes T30	C0149931; Migraine Disorders; Disease or Syndrome
T31	DISO 1828 1836	cefaleas
#23	AnnotatorNotes T31	C0018681; Headache; Sign or Symptom
T32	DISO 1857 1875	cefalea en racimos
#24	AnnotatorNotes T32	C0009088; Cluster Headache; Disease or Syndrome
T33	DISO 1878 1907	cefalea migrañosa hemipléjica
T34	PROC 653 661	tratados
#25	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	PROC 2045 2056	tratamiento
#26	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	CHEM 2074 2099	fármacos en investigación
#27	AnnotatorNotes T36	C0013230; Investigational New Drugs; Pharmacologic Substance
T37	CHEM 2180 2204	anticuerpos monoclonales
#28	AnnotatorNotes T37	C0003250; Monoclonal Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T38	PROC 2355 2369	procedimientos
#29	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T39	PROC 2409 2418	protocolo
#30	AnnotatorNotes T39	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T40	PROC 2439 2453	procedimientos
#31	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T41	DISO 2522 2532	enfermedad
T42	PROC 2678 2688	evaluación
#32	AnnotatorNotes T42	C1261322; Evaluation procedure; Health Care Activity
T43	PROC 2690 2704	procedimientos
#33	AnnotatorNotes T43	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T44	CHEM 176 184	erenumab
#34	AnnotatorNotes T44	C4542165; erenumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T45	PROC 163 171	tratados
#35	AnnotatorNotes T45	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T46	CHEM 431 439	erenumab
#36	AnnotatorNotes T46	C4542165; erenumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T47	DISO 1260 1263	SII
#37	AnnotatorNotes T47	C0022104; Irritable Bowel Syndrome; Disease or Syndrome
T48	PROC 1936 1949	procedimiento
#38	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T49	PROC 348 352	CVRS
T50	Date 12 16	2019
T51	LIVB 77 84	sujetos
#39	AnnotatorNotes T51	C0681850; Study Subject; Group
T52	Duration 97 104	crónica
#40	AnnotatorNotes T52	C0205191; chronic; Temporal Concept
T54	Duration 266 274	12 meses
T55	LIVB 357 366	pacientes
#41	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Duration 379 386	crónica
#42	AnnotatorNotes T56	C0205191; chronic; Temporal Concept
T58	LIVB 567 574	sujetos
#43	AnnotatorNotes T58	C0681850; Study Subject; Group
T59	Duration 587 594	crónica
#44	AnnotatorNotes T59	C0205191; chronic; Temporal Concept
T61	LIVB 833 840	Adultos
#45	AnnotatorNotes T61	C0001675; Adult; Age Group
T62	Age 841 849	≥18 años
T63	LIVB 893 901	Paciente
#46	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Duration 928 935	crónica
#47	AnnotatorNotes T64	C0205191; chronic; Temporal Concept
T66	Neg_cue 974 977	sin
T67	Duration 992 1007	al menos un año
T68	LIVB 1116 1124	Paciente
#48	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Duration 1236 1243	crónica
#49	AnnotatorNotes T69	C0205191; chronic; Temporal Concept
T71	LIVB 1286 1295	pacientes
#50	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T73	Duration 1533 1541	≥10 días
T76	LIVB 1711 1718	Sujetos
#51	AnnotatorNotes T76	C0681850; Study Subject; Group
T77	Age 1719 1737	mayores de 50 años
T78	LIVB 1774 1781	Sujetos
#52	AnnotatorNotes T78	C0681850; Study Subject; Group
T80	DEVI 1922 1933	dispositivo
#53	AnnotatorNotes T80	C1285539; Direct device; Medical Device
T81	Duration 1958 1969	los 2 meses
T82	Duration 2108 2119	5 semividas
T85	LIVB 2592 2604	investigador
#54	AnnotatorNotes T85	C0035173; Research Personnel; Professional or Occupational Group
T88	LIVB 2652 2658	sujeto
#55	AnnotatorNotes T88	C0681850; Study Subject; Group
T74	PHYS 2220 2242	efecto farmacodinámico
#56	AnnotatorNotes T74	C1735339; Drug-drug pharmacodynamic interaction; Clinical Attribute
T70	PROC 1595 1601	diario
#57	AnnotatorNotes T70	C2216446; maintain symptom diary; Health Care Activity (?)
T72	PROC 1641 1647	diario
#58	AnnotatorNotes T72	C2216446; maintain symptom diary; Health Care Activity (?)
T53	PROC 2124 2137	reclutamiento
#59	AnnotatorNotes T53	C0242800; Patient Recruitment; Research Activity
T57	Spec_cue 2311 2325	Improbabilidad
T60	PROC 2372 2379	visitas
#60	AnnotatorNotes T60	C1512346; Patient Visit; Health Care Activity
A2	Assertion T16 Negated
A1	Status T32 History_of
A3	Status T33 History_of
A4	Status T80 History_of
A5	Status T48 History_of
A6	Status T41 History_of
A7	Status T28 History_of
A8	Status T22 History_of
A9	Status T25 History_of
A10	Assertion T38 Speculated
A11	Assertion T40 Speculated
A12	Assertion T60 Speculated
#61	AnnotatorNotes T2	C0744638; headache migraine chronic; Disease or Syndrome + C4760993; Episodic migraine; Disease or Syndrome
#62	AnnotatorNotes T7	C0744638; headache migraine chronic; Disease or Syndrome + C4760993; Episodic migraine; Disease or Syndrome
#63	AnnotatorNotes T11	C0744638; headache migraine chronic; Disease or Syndrome + C4760993; Episodic migraine; Disease or Syndrome
#64	AnnotatorNotes T15	C0744638; headache migraine chronic; Disease or Syndrome + C4760993; Episodic migraine; Disease or Syndrome
#65	AnnotatorNotes T1	C0281588; Assessment of quality of life; Diagnostic Procedure 
#66	AnnotatorNotes T10	C0281588; Assessment of quality of life; Diagnostic Procedure 
T65	Neg_cue 1786 1788	no
T75	CONC 1796 1807	diferenciar
A13	Assertion T75 Negated
T79	Spec_cue 2606 2613	pudiera
T83	Observation 2625 2647	riesgo en la seguridad
A14	Assertion T83 Speculated
R1	Negation Arg1:T66 Arg2:T16	
R2	Negation Arg1:T65 Arg2:T75	
R3	Speculation Arg1:T57 Arg2:T38	
R4	Speculation Arg1:T57 Arg2:T60	
R5	Speculation Arg1:T57 Arg2:T40	
R6	Speculation Arg1:T79 Arg2:T83	
T84	CONC 2661 2671	interferir
A15	Assertion T84 Speculated
#67	AnnotatorNotes T84	C0521102; Interferes with; Functional Concept
R7	Speculation Arg1:T79 Arg2:T84	
T86	Quantifier_or_Qualifier 120 135	alta frecuencia
#68	AnnotatorNotes T86	C0205212; High frequency; Temporal Concept
T87	Quantifier_or_Qualifier 951 966	alta frecuencia
#69	AnnotatorNotes T87	C0205212; High frequency; Temporal Concept
T89	Quantifier_or_Qualifier 402 417	alta frecuencia
#70	AnnotatorNotes T89	C0205212; High frequency; Temporal Concept
R8	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T89	
R9	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T86	
T90	Quantifier_or_Qualifier 610 625	alta frecuencia
#71	AnnotatorNotes T90	C0205212; High frequency; Temporal Concept
R10	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T90	
R11	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T87	
R12	Has_Duration_or_Interval Arg1:T2 Arg2:T52	
R13	Experiences Arg1:T51 Arg2:T2	
R14	Experiences Arg1:T51 Arg2:T3	
R15	Overlap Arg1:T2 Arg2:T3	
R16	Used_for Arg1:T44 Arg2:T45	
R17	Experiences Arg1:T51 Arg2:T45	
R18	Has_Duration_or_Interval Arg1:T5 Arg2:T54	
R19	Used_for Arg1:T46 Arg2:T21	
R20	Overlap Arg1:T7 Arg2:T8	
R21	Experiences Arg1:T55 Arg2:T7	
R22	Experiences Arg1:T55 Arg2:T21	
R23	Experiences Arg1:T55 Arg2:T8	
R24	Used_for Arg1:T46 Arg2:T5	
R25	Has_Duration_or_Interval Arg1:T46 Arg2:T54	
R26	Experiences Arg1:T58 Arg2:T11	
R27	Has_Duration_or_Interval Arg1:T11 Arg2:T59	
R28	Overlap Arg1:T11 Arg2:T12	
R29	Experiences Arg1:T58 Arg2:T12	
R30	Used_for Arg1:T24 Arg2:T34	
R31	Experiences Arg1:T58 Arg2:T34	
T91	Observation 801 828	participación en el estudio
#72	AnnotatorNotes T91	C1278516; Patient participation status; Finding (?)
R32	Before Arg1:T13 Arg2:T91	
R33	Has_Age Arg1:T61 Arg2:T62	
T92	PROC 878 887	selección
#73	AnnotatorNotes T92	C0242802; Patient Selection; Research Activity
R34	Overlap Arg1:T92 Arg2:T62	
R35	Experiences Arg1:T63 Arg2:T15	
R36	Has_Duration_or_Interval Arg1:T15 Arg2:T64	
R37	Overlap Arg1:T15 Arg2:T16	
R38	Has_Duration_or_Interval Arg1:T15 Arg2:T67	
T93	PROC 1020 1029	selección
#74	AnnotatorNotes T93	C0242802; Patient Selection; Research Activity
R39	Before Arg1:T15 Arg2:T93	
T94	CONC 1039 1101	International Classification of Headache Disorders-3rd Edition
T95	CONC 1103 1109	ICHD-3
R40	Used_for Arg1:T94 Arg2:T14	
R41	Used_for Arg1:T95 Arg2:T14	
R42	Experiences Arg1:T68 Arg2:T18	
R43	Has_Duration_or_Interval Arg1:T19 Arg2:T69	
R44	Experiences Arg1:T68 Arg2:T19	
R45	Experiences Arg1:T68 Arg2:T20	
R46	Experiences Arg1:T68 Arg2:T47	
T96	CONC 1162 1178	historia clínica
#75	AnnotatorNotes T96	C5204342; Clinical History; Intellectual Product
R47	Experiences Arg1:T71 Arg2:T28	
R48	Used_for Arg1:T22 Arg2:T28	
R49	Experiences Arg1:T71 Arg2:T23	
T97	CONC 1392 1409	periodo de lavado
#76	AnnotatorNotes T97	C1710661; Washout Period; Temporal Concept
R50	Before Arg1:T28 Arg2:T97	
R51	Used_for Arg1:T25 Arg2:T28	
R52	Before Arg1:T25 Arg2:T97	
R53	Has_Duration_or_Interval Arg1:T26 Arg2:T73	
T98	CONC 1565 1575	fase basal
#77	AnnotatorNotes T98	C1442488; Baseline; Quantitative Concept
R54	Overlap Arg1:T27 Arg2:T98	
R55	Overlap Arg1:T26 Arg2:T98	
T99	Quantifier_or_Qualifier 1602 1613	electrónico
#78	AnnotatorNotes T99	C0013850; Electronic; Idea or Concept
R56	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T99	
T100	Observation 1618 1630;1637 1659	Cumplimiento del diario electrónico
T101	Result_or_Value 1631 1636	≥80 %
R59	Has_Result_or_Value Arg1:T100 Arg2:T101	
T102	CONC 1671 1681	fase basal
#79	AnnotatorNotes T102	C1442488; Baseline; Quantitative Concept
R60	Overlap Arg1:T100 Arg2:T102	
R61	Overlap Arg1:T72 Arg2:T102	
R62	Has_Age Arg1:T76 Arg2:T77	
T103	CONC 1749 1755	inicio
#80	AnnotatorNotes T103	C0439659; Beginning; Temporal Concept
R63	Overlap Arg1:T103 Arg2:T77	
R64	Experiences Arg1:T76 Arg2:T29	
R65	Experiences Arg1:T78 Arg2:T30	
R66	Experiences Arg1:T78 Arg2:T31	
R67	Has_Duration_or_Interval Arg1:T80 Arg2:T81	
R68	Has_Duration_or_Interval Arg1:T48 Arg2:T81	
T104	CONC 1997 2002	basal
#81	AnnotatorNotes T104	C1442488; Baseline; Quantitative Concept
T105	CONC 2015 2020	basal
#82	AnnotatorNotes T105	C1442488; Baseline; Quantitative Concept
R69	Before Arg1:T80 Arg2:T104	
R70	Before Arg1:T48 Arg2:T104	
R71	Overlap Arg1:T80 Arg2:T105	
R72	Overlap Arg1:T48 Arg2:T105	
R73	Overlap Arg1:T80 Arg2:T35	
R74	Overlap Arg1:T48 Arg2:T35	
#83	AnnotatorNotes T33	C0270862; Hemiplegic migraine; Disease or Syndrome
R75	Has_Duration_or_Interval Arg1:T36 Arg2:T82	
T106	CONC 2140 2157	periodo de lavado
#84	AnnotatorNotes T106	C1710661; Washout Period; Temporal Concept
T107	Quantifier_or_Qualifier 2158 2168	inadecuado
#85	AnnotatorNotes T107	C0205412; Inadequate (qualifier); Qualitative Concept
R77	Has_Quantifier_or_Qualifier Arg1:T106 Arg2:T107	
R78	Before Arg1:T37 Arg2:T106	
T108	Observation 2220 2242;2252 2273	efecto farmacodinámico vuelva al nivel basal
R79	Before Arg1:T37 Arg2:T74	
R80	Before Arg1:T37 Arg2:T108	
T109	Quantifier_or_Qualifier 2545 2571	clínicamente significativa
T110	Observation 2533 2542	inestable
A16	Status T110 History_of
#86	AnnotatorNotes T110	C0443343; Unstable status; Finding 
R81	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T110	
R82	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T109	
A17	Status T109 History_of
#87	AnnotatorNotes T41	C0012634; Disease; Disease or Syndrome
R83	Before Arg1:T41 Arg2:T83	
R84	Experiences Arg1:T88 Arg2:T83	
R85	Experiences Arg1:T88 Arg2:T42	
R87	Experiences Arg1:T88 Arg2:T43	
#88	AnnotatorNotes T109	C5209294; Clinical relevance; Intellectual Product
R88	Has_Duration_or_Interval Arg1:T7 Arg2:T56	
R89	Before Arg1:T14 Arg2:T93	
T111	CONC 2262 2273	nivel basal
#89	AnnotatorNotes T111	C1442488; Baseline; Quantitative Concept
R57	Experiences Arg1:T88 Arg2:T41	
#90	AnnotatorNotes T95	[International Classification of Headache Disorders vs 3]
A18	Assertion T97 Hypothetical
A19	Experiencer T71 Patient
A20	Experiencer T76 Patient
A21	Experiencer T78 Patient
A22	Experiencer T85 Other
A23	Experiencer T88 Patient
A24	Experiencer T51 Patient
A25	Experiencer T55 Patient
A26	Experiencer T58 Patient
A27	Experiencer T61 Patient
A28	Experiencer T63 Patient
A29	Experiencer T68 Patient
A30	Assertion T37 Hypothetical
